Observing patients with severe allergic reactions
Official title: Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
Run by Charite University, Berlin, Germany · NCT05210543 · Data updated 2026-11-12
This study looks at patients who have had severe allergic reactions to better understand what causes them and how to manage them in the future.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Berlin) |
| Status | Recruiting |
| Started | January 1, 2007 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | August 21, 2024 |
| Trial ID | NCT05210543 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals who have experienced an anaphylactic reaction within the past 12 months.
✕Probably not a fit
Patients who have not had an anaphylactic reaction in the past year will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Anaphylaxis Registry collects standardized data on symptoms, triggers, cofactors, and therapy management from patients who have experienced anaphylaxis. This observational study aims to enhance the understanding of anaphylactic reactions, which could lead to improved diagnosis and long-term management strategies. Optional blood sampling may provide insights into sensitization profiles and potential biomarkers associated with these reactions. By identifying triggers and understanding the pathology, the study seeks to reduce the risk of future anaphylactic episodes.
Why it matters
Potential benefit: If successful, this study could lead to better diagnosis and prevention strategies for patients at risk of anaphylaxis.
How similar studies have gone: Other studies have shown success in identifying biomarkers related to anaphylaxis, suggesting that this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Anaphylactic reaction within the past 12 months Exclusion Criteria: \-
Where it's running
-
Charité - Universitätsmedizin Berlin
Berlin, Germany Recruiting
Study contacts
- Study coordinator: Margitta Worm, Prof.
- Email: margitta.worm@charite.de
- Phone: +49 30 450 518105
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
What the Mayo Clinic is learning from blood clot tests in allergic reactions
This study tests whether real-time blood clotting markers can help understand and predict the severity of allergic reactions and anaphylaxis in patients 12 and older.
-
Steroids for allergic reactions to food in children
This study will test whether giving steroids in addition to adrenaline and antihistamines helps children who have allergic reactions during supervised food challenges.
-
Different forms of IgE in health and disease.
We will test whether different forms of IgE in the blood differ between healthy adults and people with allergies, chronic spontaneous urticaria, recent anaphylaxis, mastocytosis, hereditary alpha tryptasemia, X‑linked agammaglobulinemia, or those undergoing venom/medication desensitization.
-
Inhaled epinephrine for systemic allergic reactions during allergy testing, immunotherapy, or oral challenges
This will see if inhaled epinephrine helps people 12 and older who have systemic allergic reactions during allergy testing, subcutaneous or oral immunotherapy, or oral food/drug challenges.
-
Finding causes of allergic reactions during and after surgery
This project tests whether measuring tryptase levels and doing skin tests can find the cause of suspected allergic reactions during or after surgery for patients aged 2 and older.
-
Registry for individuals with food allergies
This study is collecting health information from people with food allergies to help researchers learn more about the condition and improve treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.